https://www.thebodypro.com/author/coverage-provided-andrew-t-pavia

Latest by Andrew T. Pavia, M.D.

Promo Image

Nevirapine Well Tolerated in HIV-Infected Pregnant Women

Nevirapine (NVP, Viramune) has come to be an essential drug in the treatment of HIV-infected pregnant women. In addition to the use of single-dose nevirapine to prevent mother-to-child transmission in women in resource-poor settings, nevirapine is fr...

Promo Image

Efavirenz or Nevirapine Regimens Are More Potent Than Trizivir for Initial Therapy

This summer the results of ACTG 5095 were presented at The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment in Paris (click here for a summary), after being widely disseminated in the spring. ACTG 5095 showed that the combi...

Promo Image

No Detectable Difference in Efficacy Seen Between Efavirenz and Nevirapine

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) remain popular and important drugs in both initial regimens and for salvage. Nevirapine (NVP, Viramune) and efavirenz (EFV, Sustiva) each have advantages and disadvantages, but the direct head-...

Promo Image

Nevirapine- Versus Efavirenz-Containing Three-Drug Regimens

Systematic Review of Nevirapine- Versus Efavirenz-Containing Three-Drug Regimens for Initial Treatment of HIV Infection (Poster 552) Authored by M.D. Neuwelt, O. Bacon, G.E. Kennedy, G.W. Rutherford

If making sense of many different clinical t...

Promo Image

Another Look at Induction Maintenance Therapy

Induction of Antiretroviral-Naive HIV-Infected Subjects With Trizivir (TZV) and Sustiva (EFV) for 48 Weeks (ESS40013) (Oral 42) Authored by M. Markowitz, J. Lang, E. DeJesus, C. Hill-Zabala, E.R. Lanier, Q. Liao, K. Pappa, M. Shaefer

Induction...

Promo Image
Cardiovascular

Switch to Nevirapine From Protease Inhibitor Lowers Triglycerides and Maintains Viral Load Suppression

Long-Term Efficacy and Safety of Protease Inhibitor Switching to Nevirapine in HIV Patients With Undetectable Viral Load (Poster 590) Authored by P. Gil, M. Górgolas, V. Estrada, A. Arranz, P. Rivas, C. Yera, R. García Delgado, J.J. Granizo, M....

Promo Image

Results of the 2NN Study: A Randomized Comparative Trial of First-Line Antiretroviral Therapy With Regimens Containing Either Nevirapine Alone, Efavirenz Alone or Both Drugs Combined, Together With Stavudine and Lamivudine

Results of the 2NN Study: A Randomized Comparative Trial of First-Line Antiretroviral Therapy (ART) With Regimens Containing Either Nevirapine (NVP) Alone, Efavirenz (EFV) Alone or Both Drugs Combined, Together With Stavudine and Lamivudine (Oral 1...

Promo Image
Women

Low Bone Mineral Density in HIV-Infected Women

Low Bone Mineral Density in HIV-Infected Women (Oral 102) Authored by D. Jacobson, T. Knox, A. Shevitz, S. Gorbach View the original abstract

HIV Infection and Protease Inhibitor Use Are Not Associated With Reduced Bone Mineral Density in ...

Promo Image

Successful Switch From Stavudine to Once-Daily Tenofovir Based Regimen in Patients With Fully Suppressed HIV

Successful Switch From Stavudine to Once-Daily Tenofovir Based Regimen in Patients With Fully Suppressed HIV (Poster 449) Authored by G. Pierone, Jr., AIDS Research and Treatment Ctr. of the Treasure Coast, Vero Beach, FL; J. Mieras, C. Kantor,...

Promo Image
Women

Greater Prevalence of Anemia in Women and African Americans With HIV/AIDS in the HAART Era: A Study of 10,000 Patients

Greater Prevalence of Anemia in Women and African Americans With HIV/AIDS in the HAART Era: A Study of 10,000 Patients (Poster 475) Authored by T. Creagh, Clinical and Epidemiology Research, Atlanta, GA; D. Mildvan, Beth Israel Medical Ctr., Ne...